Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases

Journal of Ginseng Research

Volumn 42, Issue 3, 2018, Pages 264-269

  Kim, Jong Hoon ^a  

^a Chonbuk National University   (South Korea)

Author keywords

blood pressure; lipid profile; myocardial protection; Panax ginseng; vasomotor tone

Indexed keywords

GINSENOSIDE; ION CHANNEL;

ANTIOXIDANT ACTIVITY; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CIRCULATION; DRUG MECHANISM; GINSENG; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

EID: 85035193968     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2017.10.004     Document Type: Review

References (95)

1. Mahady, G.B., Gyllenhall, C., Fong, H.H., Farnsworth, N.R., Ginsengs: a review of safety and efficacy. Nutr Clin Care 3 (2000), 90–101.
2. World Health Organization, WHO monographs on selected medicinal plants. 1999, World Health Organization, Geneva.
3. Gillis, C.N., Panax ginseng pharmacology: a nitric oxide link?. Biochem Pharmacol 54 (1997), 1–8.
4. Buettner, C., Yeh, G.Y., Phillips, R.S., Mittleman, M.A., Kaptchuk, T.J., Systematic review of the effects of ginseng on cardiovascular risk factors. Ann Pharmacother 40 (2006), 83–95.
5. Lim, K.H., Lim, D.J., Kim, J.H., Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach. J Ginseng Res 37 (2013), 283–292.
6. Attele, A.S., Wu, J.A., Yuan, C.S., Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58 (1999), 1685–1693.
7. Zhou, W., Chai, H., Lin, P.H., Lumsden, A.B., Yao, Q., Chen, C.J., Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 10 (2004), 187–192.
8. Cheng, Y., Shen, L.H., Zhang, J.T., Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 26 (2005), 143–149.
9. Lim, K.H., Ko, D., Kim, J.H., Cardioprotective potential of Korean Red Ginseng extract on isoproterenol-induced cardiac injury in rats. J Ginseng Res 37 (2013), 273–282.
10. Toth, P.P., Making a case for quantitative assessment of cardiovascular risk. J Clin Lipidol 1 (2007), 234–241.
11. Libby, P., Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques. J Am Coll Cardiol 45 (2005), 1600–1602.
12. Davies, M.J., Gordon, J.L., Gearing, A.J., Pigott, R., Woolf, N., Katz, D., Kyriakopoulos, A., The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and Eselectin in human atherosclerosis. J Pathol 171 (1993), 223–229.
13. Qi, L.W., Wang, C.Z., Yuan, C.S., Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 28 (2011), 467–495.
14. Sengupta, S., Toh, S.A., Sellers, L.A., Skepper, J.N., Koolwijk, P., Leung, H.W., Yeung, H.W., Wong, R.N.S., Sasisekharan, R., Fan, T.P.D., Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110 (2004), 1219–1225.
15. Nah, S.Y., Kim, D.H., Rhim, H., Ginsenosides: are any of them candidates for drugs acting on the central nervous system?. CNS Drug Rev 13 (2007), 381–404.
16. Leung, K.S., Chan, K., Bensoussan, A., Munroe, M.J., Application of atmospheric pressure chemical ionisation mass spectrometry in the identification and differentiation of Panax species. Phytochem Anal 18 (2007), 146–150.
17. Kaneko, H., Nakanishi, K., Proof of the mysterious efficacy of ginseng: basic effects of medical ginseng, Korean red ginseng: its anti-stress action for prevention of disease. J Pharmacol Sci 95 (2004), 158–162.
18. Kasai, R., Besso, H., Tanaka, O., Saruwatari, Y., Fuwa, T., Saponins of red ginseng. Chem Pharm Bull (Tokyo) 31 (1983), 2120–2125.
19. Kim, S.I., Park, J.H., Ryu, J.H., Park, J.D., Lee, Y.H., Park, J.H., Kim, T.H., Baek, N.I., Ginsenoside Rg5, a genuine dammarane glycoside from Korean red ginseng. Arch Pharm Res 19 (1996), 551–553.
20. Ryu, J.H., Park, J.H., Eun, J.H., Jung, J.H., Sohn, D.H., A dammarane glycoside from Korean red ginseng. Phytochemistry 44 (1997), 931–933.
21. Park, J.D., Lee, Y.H., Kim, S.I., Ginsenoside Rf2, a new dammarane glycoside from Korean red ginseng (Panax ginseng). Arch Pharm Res 21 (1998), 615–617.
22. Kwon, S.W., Han, S.B., Park, I.H., Kim, J.M., Park, M.K., Park, J.H., Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J Chromatogr A 921 (2001), 335–339.
23. Kim, W.Y., Kim, J.M., Han, S.B., Lee, S.K., Kim, N.D., Park, M.K., Kim, C.K., Park, J.H., Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 63 (2000), 1702–1704.
24. Lee, C.H., Kim, J.H., A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 38 (2014), 161–166.
25. Jin, Z.Q., Liu, C.M., Effect of ginsenoside Re on the electrophysiological activity of the heart. Planta Med 60 (1994), 192–193.
26. Bai, C.X., Sunami, A., Namiki, T., Sawanobori, T., Furukawa, T., Electrophysiological effects of ginseng and ginsenoside Re in Guinea pig ventricular myocytes. Eur J Pharmacol 476 (2003), 35–44.
27. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in Guinea pig cardiomyocytes. Br J Pharmacol 142 (2004), 567–575.
28. 2+ channel subtypes. Mol Cells 21 (2006), 52–62.
29. 2+ channel current inhibitions. Biol Pharm Bull 32 (2009), 1224–1230.
30. Furukawa, T., Bai, C.X., Kaihara, A., Ozaki, E., Kawano, T., Nakaya, Y., Awais, M., Sato, M., Umezawa, Y., Kurokawa, J., Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones. Mol Pharmacol 70 (2006), 1916–1924.
31. 2+-activated Cl- current by microinjection of inositol hexakisphosphate in Xenopus laevis oocytes: involvement of GRK2 and beta-arrestin I. J Biol Chem 279 (2004), 9912–9921.
32. Xue, J.F., Liu, Z.J., Hu, J.F., Chen, H., Zhang, J.T., Chen, N.H., Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. Brain Res 1106 (2006), 91–98.
33. Chen, X.C., Zhou, Y.C., Chen, Y., Zhu, Y.G., Fang, F., Chen, L.M., Ginsenoside Rg1 reduces MPTP induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol S 26 (2005), 56–62.
34. Choi, K., Kim, M., Ryu, J., Choi, C., Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci Lett 421 (2007), 37–41.
35. Bolli, R., Superoxide dismutase 10 years later: a drug in search of a use. J Am Coll Cardiol 18 (1991), 231–233.
36. Li, J., Ichikawa, T., Jin, Y., Hofseth, L.J., Nagarkatti, P., Nagarkatti, M., Windust, A., Cui, T., An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol 130 (2010), 222–230.
37. 2-induced oxidative stress in HepG2 hepatoma cells. J Ginseng Res 37 (2013), 442–450.
38. Chen, X., Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 23 (1996), 728–732.
39. Zhou, W., Chai, H., Lin, P.H., Lumsden, A.B., Yao, Q., Chen, C., Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 41 (2005), 861–868.
40. Wang, X., Chai, H., Yao, Q., Chen, C., Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr 44 (2007), 493–499.
41. Xie, J.T., Shao, Z.H., Vanden Hoek, T.L., Chang, W.T., Li, J., Mehendale, S., Wang, C.Z., Hsu, C.W., Becker, L.B., Yin, J.J., et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 532 (2006), 201–207.
42. Deng, H.L., Zhang, J.T., Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin Med J (Engl) 104 (1991), 395–398.
43. He, F., Guo, R., Wu, S.L., Sun, M., Li, M., Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. J Cardiovasc Pharmacol 50 (2007), 314–320.
44. Kim, Y.M., Namkoong, S., Yun, Y.G., Hong, H.D., Lee, Y.C., Ha, K.S., Lee, H., Kwon, H.J., Kwon, Y.G., Kim, Y.M., Water extract of Korean red ginseng stimulates angiogenesis by activating the Pi3k/Akt-dependent Erk1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol Pharm Bull 30 (2007), 1674–1679.
45. Nakaya, Y., Mawatari, K., Takahashi, A., Harada, N., Hata, A., Yasui, S., The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through Pi3k/Akt and nitric oxide pathways. J Med Invest 54 (2007), 381–384.
46. Lei, Y., Gao, Q., Chen, K.J., Effects of extracts from Panax notoginseng and Panax ginseng fruit on vascular endothelial cell proliferation and migration in vitro. Chin J Integr Med 14 (2008), 37–41.
47. Wan, J.B., Lee, S.M., Wang, J.D., Wang, N., He, C.W., Wang, Y.T., Kang, J.X., Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. J Agric Food Chem 57 (2009), 6692–6697.
48. Hien, T.T., Kim, N.D., Pokharel, Y.R., Oh, S.J., Lee, M.Y., Kang, K.W., Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent Pi3-kinase and Amp-activated protein kinase. Toxicol Appl Pharmacol 246 (2010), 171–183.
49. Furchgott, R.F., Vanhoutte, P.M., Endothelium-derived relaxing and contracting factors. FASEB J 53 (1989), 557–573.
50. Moncada, S., Palmer, R.M., Higgs, E.A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991), 109–142.
51. Yu, J., Eto, M., Akishita, M., Kaneko, A., Ouchi, Y., Okabe, T., Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem Biophys Res Commun 353 (2007), 764–769.
52. Leung, K.W., Cheng, Y.K., Mak, N.K., Chan, K.K., Fan, T.P., Wong, R.N., Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 580 (2006), 3211–3216.
53. Kang, Y.J., Sohn, J.T., Chang, K.C., Relaxation of canine corporal smooth muscle relaxation by ginsenoside saponin Rg3 is independent from eNOS activation. Life Sci 77 (2005), 74–84.
54. Jovanovski, E., Jenkins, A., Dias, A.G., Peeva, V., Sievenpiper, J., Arnason, J.T., Rahelic, D., Josse, R.G., Vuksan, V., Effects of Korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals. Am J Hypertens 23 (2010), 469–472.
55. Lee, J.Y., Lim, K.M., Kim, S.Y., Bae, O.N., Noh, J.Y., Chung, S.M., Kim, K., Shin, Y.S., Lee, M.Y., Chung, J.H., Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng. Toxicol Sci 117 (2010), 505–514.
56. Wang, T., Yu, X.F., Qu, S.C., Xu, H.L., Sui, D.Y., Ginsenoside Rb3 inhibits angiotensin II induced vascular smooth muscle cells proliferation. Basic Clin Pharmacol Toxicol 107 (2010), 685–689.
57. Rhee, M.Y., Kim, Y.S., Bae, J.H., Nah, D.Y., Kim, Y.K., Lee, M.M., Kim, H.Y., Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. J Altern Complement Med 17 (2011), 45–49.
58. Shin, W., Yoon, J., Oh, G.T., Ryoo, S., Korean red ginseng inhibits arginase and contributes to endothelium-dependent vasorelaxation through endothelial nitric oxide synthase coupling. J Ginseng Res 37 (2013), 64–73.
59. Jeon, B.H., Kim, C.S., Park, K.S., Lee, J.W., Park, J.B., Kim, K.J., Kim, S.H., Chang, S.J., Nam, K.Y., Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol 35 (2000), 135–141.
60. Vuksan, V., Stavro, M., Woo, M., Leiter, L.A., Sung, M.K., Sievenpiper, J.L., Korean red ginseng (Panax ginseng) can lower blood pressure in individuals with hypertension: a randomized controlled trial. Proceedings of the 9th International Ginseng symposium. Geumsan: Korean Society of Ginseng, 2006, 35–36.
61. Baek, E.B., Yoo, H.Y., Park, S.J., Chung, Y.S., Hong, E.K., Kim, S.J., Inhibition of arterial myogenic responses by a mixed aqueous extract of Salvia miltiorrhiza and Panax notoginseng (PASEL) showing antihypertensive effects. Korean J Physiol Pharmacol 13 (2009), 287–293.
62. Wagner, H.N., Liu, X., The international textbook of cardiology. 1987, Pergamon Press, New York.
63. Qin, N., Gong, Q.H., Wei, L.W., Wu, Q., Huang, X.N., Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. Biol Pharm Bull 31 (2008), 1530–1535.
64. Deng, J., Wang, Y.W., Chen, W.M., Wu, Q., Huang, X.N., Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull 33 (2010), 631–635.
65. Wu, Y., Xia, Z.Y., Dou, J., Zhang, L., Xu, J.J., Zhao, B., Lei, S., Liu, H.M., Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep 38 (2011), 4327–4335.
66. Zhou, H., Hou, S.Z., Luo, P., Zeng, B., Wang, J.R., Wong, Y.F., Jiang, Z.H., Liu, L., Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated risk pathway in an endothelial NOS-dependent mechanism. J Ethnopharmacol 135 (2011), 287–298.
67. Wang, Y.L., Wang, C.Y., Zhang, B.J., Zhang, Z.Z., Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro. Mol Biol Rep 36 (2009), 365–370.
68. Zhu, D., Wu, L., Li, C.R., Wang, X.W., Ma, Y.J., Zhong, Z.Y., Zhao, H.B., Cui, J., Xun, S.F., Huang, X.L., et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 108 (2009), 117–124.
69. Kim, T.H., Lee, S.M., The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart. Food Chem Toxicol 48 (2010), 1516–1520.
70. Guo, J., Gan, X.T., Haist, J.V., Rajapurohitam, V., Zeidan, A., Faruq, N.S., Karmazyn, M., Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. Circ Heart Fail 4 (2011), 79–88.
71. Tsutsumi, Y.M., Tsutsumi, R., Mawatari, K., Nakaya, Y., Kinoshita, M., Tanaka, K., Oshita, S., Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/Pi3k pathway. Life Sci 88 (2011), 725–729.
72. Tamura, Y., Effects of Korean red ginseng on eicosanoid biosynthesis in platelets and vascular smooth muscle cells. Proceedings of the 6th International Ginseng symposium, 1993, Korean Society of Ginseng, Seoul, 28–29.
73. Dong-Ha Lee, D.H., Cho, H.J., Kim, H.H., Rhee, M.H., Ryu, J.H., Park, J.H., Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser157 phosphorylation on thrombin-induced platelet aggregation. J Ginseng Res 37 (2013), 176–186.
74. Jin, Y.R., Yu, J.Y., Lee, J.J., You, S.H., Chung, J.H., Noh, J.Y., Im, J.H., Han, X.H., Kim, T.J., Shin, K.S., et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 100 (2007), 170–175.
75. Lee, W.M., Kim, S.D., Park, M.H., Cho, J.Y., Park, H.J., Seo, G.S., Rhee, M.H., Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. J Pharm Pharmacol 60 (2008), 1531–1536.
76. Yang, J.Y., Sun, K., Wang, C.S., Guo, J., Xue, X., Liu, Y.Y., Zheng, J., Fan, J.Y., Liao, F.L., Han, J.Y., Improving effect of post-treatment with Panax notoginseng saponins on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Clin Hemorheol Microcirc 40 (2008), 119–131.
77. Lee, Y.H., Lee, B.K., Choi, Y.J., Yoon, I.K., Chang, B.C., Gwak, H.S., Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int J Cardiol 145 (2010), 275–276.
78. Yi, X.Q., Li, T., Wang, J.R., Wong, V.K., Luo, P., Wong, I.Y., Jiang, Z.H., Liu, L., Zhou, H., Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling. Phytomedicine 17 (2010), 1006–1015.
79. Ahn, C.M., Hong, S.J., Choi, S.C., Park, J.H., Kim, J.S., Lim, D.S., Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res 25 (2011), 239–249.
80. Trinh, H.T., Han, S.J., Kim, S.W., Lee, Y.C., Kim, D.H., Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J Microbiol Biotechnol 17 (2007), 1127–1133.
81. Hwang, S.Y., Son, D.J., Kim, I.W., Kim, D.M., Sohn, S.H., Lee, J.J., Kim, S.K., Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res 22 (2008), 778–783.
82. Zhang, Y.G., Zhang, H.G., Zhang, G.Y., Fan, J.S., Li, X.H., Liu, Y.H., Li, S.H., Lian, X.M., Tang, Z., Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin Exp Pharmacol Physiol 35 (2008), 1238–1244.
83. Liu, G., Wang, B., Zhang, J., Jiang, H., Liu, F., Total Panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: role of downregulation of CD40 and MMP-9 expression. J Ethnopharmacol 126 (2009), 350–354.
84. Li, J., Xie, Z.Z., Tang, Y.B., Zhou, J.G., Guan, Y.Y., Ginsenoside-Rd, a purified component from Panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice. Eur J Pharmacol 652 (2011), 104–110.
85. Yuan, J., Guo, W., Yang, B., Liu, P., Wang, Q., Yuan, H., 116 cases of coronary angina pectoris treated with powder composed of Radix Ginseng, Radix Notoginseng and Succinum. J Tradit Chin Med 17 (1997), 14–17.
86. Maffei Facino, R., Carini, M., Aldini, G., Berti, F., Rossoni, G., Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention. Planta Med 65 (1999), 614–619.
87. Zhang, D., Yasuda, T., Yu, Y., Zheng, P., Kawabata, T., Ma, Y., Okada, S., Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. Free Radic Biol Med 20 (1996), 145–150.
88. Chai, H., Zhou, W., Lin, P., Lumsden, A., Yao, Q., Chen, C., Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries. Am J Physiol Heart Circ Physiol 288 (2005), H2965–H2971.
89. Toh, H.T., Improved isolated heart contractility and mitochondrial oxidation after chronic treatment with Panax ginseng in rats. Am J Chin Med 22 (1994), 275–284.
90. You, J.S., Huang, H.F., Chang, Y.L., Panax ginseng reduces adriamycin-induced heart failure in rats. Phytother Res 19 (2005), 1018–1022.
91. Choi, S.H., Shin, T.J., Lee, B.H., Chu, D.H., Choe, H., Pyo, M.K., Hwang, S.H., Kim, B.R., Lee, S.M., Lee, J.H., et al. Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit. Eur J Pharmacol 637 (2010), 138–147.
92. Kong, H.L., Wang, J.P., Li, Z.Q., Zhao, S.M., Dong, J., Zhang, W.W., Anti-hypoxic effect of ginsenoside Rb1 on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo. Acta Pharmacol Sin 30 (2009), 396–403.
93. Kim, C.S., Son, S.J., Kim, H.S., Kim, Y.D., Lee, K.S., Jeon, B.H., Kim, K.J., Park, J.K., Park, J.B., Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes. Acta Pharmacol Sin 26 (2005), 551–558.
94. Jiang, Q.S., Huang, X.N., Yang, G.Z., Jiang, X.Y., Zhou, Q.X., Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyocyte hypertrophy induced by prostaglandin F2α. Acta Pharmacol Sin 28 (2007), 1149–1154.
95. Wang, Y.G., Zima, A.V., Ji, X., Pabbidi, R., Blatter, L.A., Lipsius, S.L., Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol 295 (2008), H851–H859.